South Africa Prepares for Potential New Adult TB Vaccine

South Africa's Department of Health is preparing for the potential introduction of a new TB vaccine, M72/AS01E, currently in Phase 3 trials. This initiative aims to address the global TB epidemic by providing a more effective alternative to the century-old BCG vaccine.
The Department of Health has welcomed progress towards a new tuberculosis (TB) vaccine, while confirming preparatory work to ensure timely access for South Africans as part of ongoing efforts to eliminate the epidemic as a public health threat by 2030.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in